期刊文献+

地佐辛不同时间用药对全身麻醉苏醒的影响 被引量:12

下载PDF
导出
摘要 目的:地佐辛术中给药用于术后镇痛时,观察其不同时间用药对全身麻醉苏醒的影响。方法:择期行开腹全子宫切除术的ASAⅠ~Ⅱ级患者60例,根据地佐辛在术中的使用情况,随机分为三组,均采用静吸复合全身麻醉。术毕前60 min用药组(A组),术毕前20 min用药组(B组),对照组不给于地佐辛(C组)。记录术后苏醒时间、拔管后5 min的疼痛VAS评分和改良OAA/S评分。结果:三组在术后的VAS评分上,A组与B组之间差异无统计学意义(P>0.05),与C组比较,A组、B组评分低(P<0.01);在苏醒时间、拔管后的改良OAA/S评分上,A组与C组之间差异无统计学意义(P>0.05),与B组比较,A组、C组在手术结束后较快苏醒(P<0.01),并且改良OAA/S评分较高(P<0.01)。结论:地佐辛在术毕前20 min用药会导致苏醒时间延长,苏醒质量降低,地佐辛术中给药用于术后镇痛时,建议在手术结束前60 min左右用药。
出处 《吉林医学》 CAS 2011年第19期3955-3956,共2页 Jilin Medical Journal
  • 相关文献

参考文献9

  • 1Pandit SK, Kothary SP, Pandit UA. Kunz NR. Double - blind placebo - controlled comparison of dezocine and morphinefor post - operative pain relief[J].Can Anaesth Soe, 1985,32 (6) :583.
  • 2Cohen RI,Edwards WT,Kezer EA,et al. Serial intravenous doses of dezocine, morphine, and nalbuphine in the management ofpostoperative pain for outpatients [J].Anesth Analg, 1993,77 (3) :533.
  • 3李丽,陈华永.地佐辛与芬太尼用于腹腔镜胃癌根治术后镇痛效果的比较[J].中国临床实用医学,2010,4(10):173-174. 被引量:92
  • 4岳修勤.地佐辛与芬太尼应用于术后静脉镇痛的临床效果比较[J].中国疼痛医学杂志,2010,16(4):255-255. 被引量:606
  • 5Pandit UA, Kothary SP,Pandit SK. Intravenous dezocine for postoperative pain : a double - blind, placebo - controlled compari-son with morphine[J]. Clin Pharmacol,1986,26(4) :275.
  • 6O' Brien J J, Benfield P. Dezocine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and thera- peutic efficacy [ J ]. Drugs, 1989,38 (2) :226.
  • 7Pandit UA, Kothary SP, Pandit SK. Intravenous dezocine forpostoperative pain : a double - blind, placebo - controlled compari- son with morphine [ J ]. Clin Pharmacol, 1986,26 (4) :275.
  • 8钟涛,郭曲练,潘韫丹.麻醉深度指数与脑电双频谱指数测定靶控输注异丙酚患者镇静时镇静深度的比较[J].中华麻醉学杂志,2005,25(12):894-897. 被引量:40
  • 9Fragen RJ, Caldwell N. Comparison of dezocine (WY 16,225) and meperidine as postoperative analgesics [ J ]. Anesth Analg, 1978,57 (5) :563.

二级参考文献16

  • 1刘华.镇痛泵在妇产科手术后应用体会[J].临床和实验医学杂志,2007,6(2):117-117. 被引量:5
  • 2Peng WH, Sandler AN. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology, 1999,90 (2) :576-599.
  • 3Kreuer S,Bruhn J,Larsen R,et al.Comparison of Alaris AEP index and bispectral index during propofol-remifentanil.Br J Anaesth,2003,91:336-340.
  • 4Smith WD,Dutton RC,Smith NT.A measure of association for assessing prediction accuracy that is a generalization of non-parametric ROC area.Stat Med,1996,15:1199-1215.
  • 5Smith WD,Dutton RC,Smith NT.Measuring the performance of anesthetic depth indicators.Anesthesiology,1996,84:38-51.
  • 6Schmidt GN,Bischoff P,Standl T,et al.Comparative evaluation of the Datex-Ohmeda S/5 Entropy Module and the Bispectral Index monitor during propofol-remifentanil anesthesia.Anesthesiology,2004,101:1283-1290.
  • 7Struys MM,Vereecke H,Moerman A,et al.Ability of the bispectral index,autoregressive modelling with exogenous input-derived auditory evoked potentials,and predicted propofol concentrations to measure patient responsiveness during anesthesia with propofol and remifentanil.Anesthesiology,2003,99:802-812.
  • 8Bruhn J,Bouillon TW,Radulescu L,et al.Correlation of approximate entropy,bispectral index,and spectral edge frequency 95 (SEF95) with clinical signs of "anesthetic depth" during coadministration of propofol and remifentanil.Anesthesiology,2003,98:621-627.
  • 9Drummond JC.Monitoring depth of anesthesia:with emphasis on the application of the Bispectral Index and the middle latency auditory evoked response to the prevention of recall.Anesthesiology,2000,93:876-882.
  • 10Milne SE,Troy A,Irwin MG,et al.Relationship between bispectral index,auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points.Br J Anaesth,2003,90:127-131.

共引文献684

同被引文献95

  • 1段砺瑕,李晓玲.氟比洛芬酯注射液的药理作用及临床应用[J].中国新药杂志,2004,13(9):851-852. 被引量:602
  • 2陈兴东,史正山,林宁,周志强,段满林,徐建国.舒芬太尼和芬太尼麻醉对患者气管插管时心血管反应的影响[J].临床麻醉学杂志,2006,22(8):614-615. 被引量:49
  • 3曾因明,邓小明,主译.米勒麻醉学.第6版.北京:北京大学医学出版社,2006;1637-1668.
  • 4吴树荣.地佐辛的药效学和药动学及其疗效初评.世界临床药物,1990,:48-48.
  • 5刘新.539例全麻手术患者苏醒期躁动原因分析及护理[J].中华护理杂志,2007,42(10):886-888. 被引量:114
  • 6姚尚龙,王俊科主编.临床麻醉学.第l版.北京:人民卫生出版社,2004.44.
  • 7Cohen RI,Edwards WT,Kezer EA,et al.Serial intravenous dosesof dezocine,morphine and nalbuphine in the management of post-operative pain for outpatients[J].Anesth Analg,1993,77(3):533-539.
  • 8Ding Y,White PF.Comparative effects of ketorolac,dezocine,andfentanyl as adjuvants during outpatient anesthesia[J].AnesthAnalg,1992,75(4):566-571.
  • 9Strain EC,Preston KL,Liebson IA,et al.Opioid antagonist effectsof dezocine in opioid-dependent humans[J].Clin Pharmacol Ther,1996,60(2):206-217.
  • 10Chris J,Shujuan M,Madeline U,et al.Discovery of mu-opioid se-lective ligands derived from 1-aminotetralin scaffolds made v iametal-catalyzed ring-opening reactions[J].Bioorg Med Chem Lett,2009,15(4):1228-1232.

引证文献12

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部